$Cassava Sciences (SAVA.US)$ Adam F from Stat News Finally A...
$Cassava Sciences (SAVA.US)$ Adam F from Stat News Finally Admitting that SAVA might help mild patients but saying that won’t be enough is just plain stupid. Anyone with a brain understands that if you treat mild AD patients early on then you protect them from diving into moderate. All the other current AD drugs that have been rejected cause brain bleeding, swelling and 4 death cases. SAVA has been deemed safe by FDA, slowed decline and improved cognition for mild patients wanting to stay on OLE extension with possibilities of treating other debilitating diseases as well through other studies from different scientists showing the benefits of filamin A , repairing misfolded protein. SAVA is a Breakthrough for AD patients
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
